BDNF and Huntington disease: Similarly, mesenchymal stem cells (MSCs) genetically altered to overexpress BDNF have been shown to reduce neuropathological and behavioral deficits in rodent models of HD, suggesting that these approaches have considerable potential for clinical use (for review [196]).